MPN-like disease, decreased apoptosis and cell cycle arrest in response to irradiation through bcl2 (Forrester et al., 2011); increased HSCs, oncogenesis requires dnmt1 or meis1, epigenetic therapies restore normal hematopoiesis (Deveau et al., 2015). Here, BCL2 is linked to myeloproliferative disorder.